$RGC Breaking News! Regencell Bioscience : F

$RGC Breaking News! Regencell Bioscience : Forging a New Approach to ADHD and ASD
NASDAQ:RGC

Traditional “western” medicine has made amazing advances and is one of the great innovations in history, but, unfortunately, there are still many conditions afflicting people that western medicine hasn’t been able to treat with any great effectiveness. It’s in instances like these that it can be beneficial to look to a medical approach that’s been around for over 2,000 years—a practice known as Traditional Chinese Medicine (TCM). It’s this approach that Regencell (NASDAQ:RGC) is embracing to improve the lives of the millions dealing with Attention Deficit Hyperactive Disorder (ADHD) and Autism Spectrum Disease (ASD) and an approach that has shown some encouraging improvements that sufferers of these conditions and their families are likely to be interested in.

Regencell Bioscience (RGC) is an early-stage bioscience company that focuses on the research, development and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD. Before getting into the specific applications for ADHD and ASD, the TCM approach to addressing health issues may be somewhat unknown to those of us in the west and it would be helpful to understand the big picture before drilling down to the specifics. According to the National Institute of Health, TCM uses various psychological and/or physical approaches as well as herbal products to address health problems, examples of these approaches include:

https://finance.yahoo.com/news/rgc-forging-ap...00757.html